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Introduction
Characterization of the glycosylation profile of a recombi-
nant protein product is an important part of defining pro-
duct quality in the bioproduction industry. Development
of a protein with desired characteristics would require the
capacity to modify and target specific glycosylation pat-
terns as well as an understanding of the implications of
changes to these glycosylation profiles. Previous cell cul-
ture studies have demonstrated the ability to modulate
glycan profiles without negative impact to culture growth
and product titer through the addition of glycosylation-
enhancing medium components. With new methods,
including increased measurement sensitivity and new cap-
abilities in RNA-Seq technology, it is possible to develop a
glycosylation gene expression profile for CHO cells. Speci-
fic glycosylation genes can then be tracked to ensure that
the addition of these compounds will not negatively
impact gene expression. Analyses comparing growth and
titer, glycan distribution, and transcriptome differences
can present us with potential insight into what changes
are taking place on a genetic level in the cell in response
to changes in medium and culture conditions.
Materials and methods
(All Materials were from Life Technologies unless other-
wise indicated)
Cell culture
CHO-S® and DG44 derived recombinant cells expressing
the same IgG molecule were grown in CD FortiCHO™
medium supplemented with 4mM L-glutamine and 1:100
Anti-Clumping Agent.
Fed-batch bioreactor
DASGIP bioreactor with 500mL initial working volume
seeded at 0.3x105 viable cells/ml in CD FortiCHO™ med-
ium. 10% CD EfficientFeed™ C (EFC) feeding on days 3, 5
and 7 for CHO-S® cultures, and feeding on days 4, 6 and
8 for DG44 cultures. Glucose concentration was main-
tained above 3g/L. Component A and/or component B
were added on the first day of feeding (day 3 for CHO-S®
and day 4 for DG44 cultures). Culture conditions were
maintained as follows; pH 7.0 +/- 0.05, 50% DO, 37°C, 110
rpm. Cell densities and viabilities were measured using a
Vi-CELL® counter (Beckman Coulter). Metabolites (glu-
cose, ammonia, lactate) and IgG were measured using a
Cedex® Bio HT Instrument (Roche).
Glycan analysis
Protein supernatant samples were collected and purified
using POROS® MabCapture® A resin. Samples glycan
profiles were analyzed on an Applied Biosystems® 3500
Series Genetic Analyzer.
Transcriptome analysis
RNA was extracted at several time points during the cul-
ture. A total of 174 potential glycosylation specific gene
targets were identified and primers designed to these
using reference sequences from Chinese hamster ovary,
mouse, rat and human. A total of 34 samples were multi-
plexed on a Proton™ PI chip on the Ion Torrent™
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Results and discussion
The use of components A and B with CHO-S® cells in
CD FortiCHO™ medium causes a considerable increase
in the level of galactosylation of the recombinant IgG
(Figure 1) as shown by the shift in the glycosylation pro-
file from G0F to G1F and G2F. The use of targeted tran-
scriptome analysis revealed that the changes observed in
the glycosylation profile do not translate to noticeable
differences in the expression levels of the glycosylation
genes. There are changes in gene expression levels with
culture age but they are not altered by the additions of
components A and/or B. It was originally theorized that
components A and B could act as cofactors or substrates
within the glycosylation enzymatic pathways but this
could not be confirmed without an understanding of the
glycosylation gene profile. The changes in the glycosyla-
tion patterns combined with the absence of changes in
the gene expression data lend support to this theory.
With this information it is apparent that the additions of
the glycosylation-enhancing components A and B can
Figure 1 Glycan analysis data measured as the percentage of total glycans. (A) The glycan profile for the CHO-S® culture with no addition
of components A and/or B. (B) These data indicate that the addition of component A to the culture results in very little change to the glycan
profile, only slight increase in the percent of G1F on days 5 and 7. (C) The addition of component B to the culture shifts the glycan profile from
primarily non-galactosylated G0F to increased G1F (single galactose) and G2F (two galactose) glycoforms. (D) The addition of both components
A and B results in a change in galactosylation indicated by the increase in both G1F and G2F and an overall reduction of G0F. In every
condition, G0F increases with time but this is minimized with the addition of both components A and B. The majority of protein glycoforms
within this experiment are fucosylated and the addition of components A and/or B does not appear to alter this.
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increase galactosylation of recombinant proteins with no
negative effect on growth, titer or glycosylation gene
expression.
The comparison between CHO-S® and DG44 cultures
without supplementation with components A or B
revealed the DG44 culture had better galactosylation
with increased proportions of G1F and G2F. Both cell
lines express high levels of DDOST, RPN1, DAD1 and
SST3A which are all part of the oligosaccharyltransfer-
ase complex which catalyzes the transfer of high man-
nose oligosaccharides from lipid-linked oligosaccharide
donors to the asparagines on the Asn-X-Ser/Thr of the
polypeptide chain. The DG44 cells differ from the
CHO-S® cells with increases in: ALG2, ALG3, ALG9
and ALG12 (mannosyltransferases), ALG8 and ALG10
(glucosyltransferases), ALG14 (acetylglucosaminyltrans-
ferase), and B4GALT5 (galactosyltransferase). These
increases in gene expression in DG44 cells seem to
coincide with the higher galactosylation profiles
observed in the glycan analysis.
Conclusions
Differences in growth, titer and glycoform distribution
were observed between CHO-S® and CHO DG44 cells.
DG44 cells had higher expression of glycosylation trans-
ferase genes compared to CHO-S® cells. Components A
and B had synergistic effects on terminal galactosylation
(Figure 1), showed no changes in gene expression and
could be acting as cofactors/substrates with glycosyla-
tion enzymes.
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